InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,002.80
(
0.00%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.59
(
0.02%
)
Bitcoin
66,848.94
(
0.66%
)
Post# of 251581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 214880

Monday, 11/20/2017 10:50:38 AM

Monday, November 20, 2017 10:50:38 AM

Post# of 251581
BHVN PR on pediatric migraine trial plan:

https://finance.yahoo.com/news/biohaven-receives-agreement-fda-initial-080000522.html

Given Peter/Biomaven’s interest in migraine and the CGRP target in particular, I think Biohaven should change its corporate name to Biomaven.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up